When is seroquel going generic

AstraZeneca losing fight against generic quetiapine [www. German court rules Seroquel XR patent invalid [www. Permission granted to reproduce for personal and non-commercial use only. Contact the publisher to obtain permission before redistributing.

All Rights Reserved. Call for drug pricing transparency. High price of cancer medicines make treatment unaffordable globally. New five-year medicines agreements in Australia. Generics applications under review by EMA — July The best selling biotechnology drugs of the next biosimilars targets. Sandoz launches ferumoxytol and pemetrexed generics. US generic approvals for Acrux and Cipla. The former is indicated for schizophrenia and the treatment of moderate to severe manic episodes, while the second drug is approved for schizophrenia and bipolar disorder, and add-on treatment for patients with major depressive disorder who have not responsed to antidepressant monotherapy.

Teva has published its price sheet which shows the considerable difference between branded and generic drugs. Free news subscriptions Free RSS feeds. Teva fast out of the blocks to sell generic Seroquel 27th March Get the latest pharma news delivered to your inbox.

Researchers recently found that antiepileptic drug use was associated with increased fall risk among older adults. The American Academy of Neurology and American Epilepsy Society have recently updated practice guidelines for the management of new-onset and treatment-resistant epilepsy with anti-epileptic drugs.

A new study found that the use of anti-epileptic drug treatment for older amnestic patients with temporal spikes improved cognitive decline and related electroencephalographic abnormalities. According to a new study, age should not be a determining factor when considering epilepsy surgery for older adult patients despite clinical bias related to age-specific surgical risks. Follow us on Twitter. Video Insights.

In this video, they break down the various clinical and potentially controversial topics that will be discussed during this 3-day event. Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for care access, and how they foresee this new indication improving rates of flu in the future.

Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion. Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and decision-making processes in pharmacy, and why it is important to appropriately use the technology functionalities that are available in practice.

Eric Maroyka, PharmD, senior director, Center for Pharmacy Practice Advancement, ASHP, discusses the recent announcement from Pfizer regarding a successful COVID vaccine, reviews the logistics of the vaccine, and highlights future challenges other vaccine trials may face that are currently underway.

Andrea Russo, MD, director, Electrophysiology and Arrhythmia Services, Cooper Hospital, discusses why there have been delays among patients making primary care visits, along with the impact this has on diagnosis, and she provides tips for health care providers—such as pharmacists that might be seeing patients more frequently than primary care doctors—on how to help patients as they wait to see Tom Knight, CEO, Invistics, discusses the challenges that drug diversion programs address, why these programs are important during the pandemic, and offers tips for health care professionals who are looking to implement these programs into practice.

Tasha Polster, vice president, pharmacy, quality, compliance and patient safety, Walgreens, discusses the measures Walgreens has taken to work with manufacturers to increase flu vaccine supply, and highlights how pharmacists can encourage and educate patients on the availability of the flu vaccine.

Julie Johnson, PharmD, and Oyunbileg Magvanjav, MD, PhD, discuss the results of their recent study that explores the relationship between prescribing rates of guideline-recommended antihypertensive drug classes and blood pressure control. Deborah Levine, MD, MPH, breaks down her recent study and explains why black individuals with a higher blood pressure level may be linked to racial disparities in cognitive decline. Specialties Autoimmune. Clinical Pathways. Population Health. Public Safety.

Wound Care. Publications Addiction Professional. Behavioral Healthcare Executive. Cath Lab Digest. EP Lab Digest. IO Learning. Journal of Clinical Pathways. Journal of Invasive Cardiology. Podiatry Today. Psych Congress Network.